الصحة والعلوم الشرق الأوسط
Mediterranean diet: scientists reveal ancient health and longevity secrets
Does Vitamin C Protect Your Heart? Health Benefits You Might Not Know
What Does "VO2 Max" Reveal About Your Health and Its Impact on Social Media Platforms
Final World Cup referee arrested for links to prostitution and drug network
Enzo controversial statement: "I don't hate the English because they clean my house"
المصدر: الصحة والعلوم الشرق الأوسط
5 Hrsجاهز للتشغيل
جاهز للتشغيل
A US clinical study has shown that an experimental vaccine targeting genetic mutations associated with pancreatic cancer elicited a strong and long-lasting immune response in at-risk individuals. The results indicated that 90% of participants developed an immune response, with a significant increase in T-cell activity and immune cells remaining present for up to two years. No cases of pancreatic cancer developed among the participants during the follow-up period, and the vaccine was well tolerated with mild side effects. This study marks an initial step toward developing preventive vaccines that target genetic mutations before symptoms appear, representing a new approach in combating this type of cancer.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading